Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Evolution of Magnetic Hyperthermia for Glioblastoma Multiforme Therapy.

Gupta R, Sharma D.

ACS Chem Neurosci. 2019 Mar 20;10(3):1157-1172. doi: 10.1021/acschemneuro.8b00652. Epub 2019 Feb 19.

PMID:
30715851
2.

Application of hyperthermia induced by superparamagnetic iron oxide nanoparticles in glioma treatment.

Silva AC, Oliveira TR, Mamani JB, Malheiros SM, Malavolta L, Pavon LF, Sibov TT, Amaro E Jr, Tannús A, Vidoto EL, Martins MJ, Santos RS, Gamarra LF.

Int J Nanomedicine. 2011;6:591-603. doi: 10.2147/IJN.S14737. Epub 2011 Mar 25. Review.

3.

Nanoparticles for hyperthermic therapy: synthesis strategies and applications in glioblastoma.

Verma J, Lal S, Van Noorden CJ.

Int J Nanomedicine. 2014 Jun 10;9:2863-77. doi: 10.2147/IJN.S57501. eCollection 2014. Review.

4.

Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.

van Tellingen O, Yetkin-Arik B, de Gooijer MC, Wesseling P, Wurdinger T, de Vries HE.

Drug Resist Updat. 2015 Mar;19:1-12. doi: 10.1016/j.drup.2015.02.002. Epub 2015 Mar 6. Review.

PMID:
25791797
5.

Biofunctionalization of magnetite nanoparticles with stevioside: effect on the size and thermal behaviour for use in hyperthermia applications.

Gupta R, Sharma D.

Int J Hyperthermia. 2019;36(1):302-312. doi: 10.1080/02656736.2019.1565787. Epub 2019 Feb 7.

PMID:
30729822
6.

Magnetic hyperthermia therapy for the treatment of glioblastoma: a review of the therapy's history, efficacy and application in humans.

Mahmoudi K, Bouras A, Bozec D, Ivkov R, Hadjipanayis C.

Int J Hyperthermia. 2018 Dec;34(8):1316-1328. doi: 10.1080/02656736.2018.1430867. Epub 2018 Feb 6.

7.

Nanomedicine associated with photodynamic therapy for glioblastoma treatment.

de Paula LB, Primo FL, Tedesco AC.

Biophys Rev. 2017 Oct;9(5):761-773. doi: 10.1007/s12551-017-0293-3. Epub 2017 Aug 19. Review.

8.

Magnetohyperthermia for treatment of gliomas: experimental and clinical studies.

Silva AC, Oliveira TR, Mamani JB, Malheiros SM, Pavon LF, Sibov TT, Amaro Junior E, Gamarra LF.

Einstein (Sao Paulo). 2010 Sep;8(3):361-7. doi: 10.1590/S1679-45082010RW1757. English, Portuguese.

9.

Harnessing nanomedicine for therapeutic intervention in glioblastoma.

Gutkin A, Cohen ZR, Peer D.

Expert Opin Drug Deliv. 2016 Nov;13(11):1573-1582. Epub 2016 Jun 27. Review.

PMID:
27292970
10.

Approaches to physical stimulation of metallic nanoparticles for glioblastoma treatment.

Pinel S, Thomas N, Boura C, Barberi-Heyob M.

Adv Drug Deliv Rev. 2019 Jan 1;138:344-357. doi: 10.1016/j.addr.2018.10.013. Epub 2018 Nov 7. Review.

11.

Current trends in targeted therapies for glioblastoma multiforme.

Ohka F, Natsume A, Wakabayashi T.

Neurol Res Int. 2012;2012:878425. doi: 10.1155/2012/878425. Epub 2012 Mar 5.

12.

Glioblastoma multiforme: State of the art and future therapeutics.

Wilson TA, Karajannis MA, Harter DH.

Surg Neurol Int. 2014 May 8;5:64. doi: 10.4103/2152-7806.132138. eCollection 2014. Review.

13.

Fighting fire with fire: the revival of thermotherapy for gliomas.

Lee Titsworth W, Murad GJ, Hoh BL, Rahman M.

Anticancer Res. 2014 Feb;34(2):565-74. Review.

PMID:
24510985
14.

RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Lozada-Delgado EL, Grafals-Ruiz N, Vivas-Mejía PE.

Life Sci. 2017 Nov 1;188:26-36. doi: 10.1016/j.lfs.2017.08.027. Epub 2017 Aug 31. Review.

15.

Recent Advances on Glioblastoma Multiforme and Nano-drug Carriers: A Review.

Liao W, Fan S, Zheng Y, Liao S, Xiong Y, Li Y, Liu J.

Curr Med Chem. 2018 May 13. doi: 10.2174/0929867325666180514113136. [Epub ahead of print]

PMID:
29768997
16.

Role of glycosyltransferase PomGnT1 in glioblastoma progression.

Lan J, Guo P, Lin Y, Mao Q, Guo L, Ge J, Li X, Jiang J, Lin X, Qiu Y.

Neuro Oncol. 2015 Feb;17(2):211-22. doi: 10.1093/neuonc/nou151. Epub 2014 Aug 1.

17.

Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.

Clark PA, Bhattacharya S, Elmayan A, Darjatmoko SR, Thuro BA, Yan MB, van Ginkel PR, Polans AS, Kuo JS.

J Neurosurg. 2017 May;126(5):1448-1460. doi: 10.3171/2016.1.JNS152077. Epub 2016 Jul 15.

18.

Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.

Reichrath S, Müller CS, Gleissner B, Pfreundschuh M, Vogt T, Reichrath J.

J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):420-4. doi: 10.1016/j.jsbmb.2010.02.028. Epub 2010 Mar 4.

PMID:
20206691
19.

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma.

Ganipineni LP, Ucakar B, Joudiou N, Bianco J, Danhier P, Zhao M, Bastiancich C, Gallez B, Danhier F, Préat V.

Int J Nanomedicine. 2018 Aug 8;13:4509-4521. doi: 10.2147/IJN.S165184. eCollection 2018.

20.

Magnetic Resonance Nano-Theranostics for Glioblastoma Multiforme.

Yao J, Hsu CH, Li Z, Kim TS, Hwang LP, Lin YC, Lin YY.

Curr Pharm Des. 2015;21(36):5256-66. Review.

PMID:
26412354

Supplemental Content

Support Center